<DOC>
	<DOCNO>NCT01903070</DOCNO>
	<brief_summary>This bi-centric , prospective , open study compare effect linagliptin active GLP-1 concentration subject renal impairment compare subject normal renal function .</brief_summary>
	<brief_title>Effects Linagliptin Active GLP-1 Concentrations Subjects With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Have Type 2 diabetes mellitus base disease diagnostic criterion ( WHO ) classification Subjects type 1 diabetes , maturity onset diabetes young ( MODY ) secondary form diabetes due pancreatitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>